The Th1 life cycle: Molecular control of IFN-γ to IL-10 switching

Trends in Immunology

Volumn 32, Issue 6, 2011, Pages 278-286

  Cope, Andrew ^a   Le Friec, Gaelle ^b   Cardone, John ^b   Kemper, Claudia ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MEMBRANE COFACTOR PROTEIN; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; HUMAN; IMMUNOPATHOLOGY; INFECTION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL;

ANIMALS; CELL PROLIFERATION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 79957713226     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.03.010     Document Type: Review

References (88)

1. Mosmann T.R., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136:2348-2357.
2. Veldhoen M., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008, 9:1341-1346.
3. Harrington L.E., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
4. Chen J., Liu X. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications. Cell. Immunol. 2009, 254:85-90.
5. Kuchroo V.K., et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 1993, 151:4371-4382.
6. Harris E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N. Engl. J. Med. 1990, 322:1277-1289.
7. Haskins K., McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990, 249:1433-1436.
8. Viallard J.F., et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1999, 115:189-195.
9. Baecher-Allan C., Hafler D.A. Human regulatory T cells and their role in autoimmune disease. Immunol. Rev. 2006, 212:203-216.
10. Jager A., Kuchroo V.K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 2010, 72:173-184.
11. Wing K., Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 2009, 11:7-13.
12. Spoerl S., Li X.C. Regulatory T cells and the quest for transplant tolerance. Discov. Med. 2011, 11:25-34.
13. Gazzinelli R.T., et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157:798-805.
14. Hunter C.A., et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 1997, 158:3311-3316.
15. Deckert M., et al. Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis. Infect. Immun. 2001, 69:4561-4571.
16. Schopf L.R., et al. IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 2002, 168:2383-2392.
17. O'Garra A., Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 2007, 7:425-428.
18. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
19. Liszewski M.K., et al. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 1991, 9:431-455.
20. Moore K.W., et al. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
21. Kuhn R., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
22. Rubtsov Y.P., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008, 28:546-558.
23. Franke A., et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 2008, 40:1319-1323.
24. Jager A., et al. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
25. Pot C., et al. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J. Interferon Cytokine Res. 2010, 30:381-388.
26. Fiorentino D.F., et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
27. Sakaguchi S., et al. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
28. Maynard C.L., et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat. Immunol. 2007, 8:931-941.
29. Sakaguchi S., et al. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010, 10:490-500.
30. Miller A., et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:421-425.
31. Roncarolo M.G., et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 2006, 212:28-50.
32. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 2006, 6:295-307.
33. Groux H., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389:737-742.
34. Bacchetta R., et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 1994, 179:493-502.
35. Grossman W.J., et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004, 104:2840-2848.
36. Apetoh L., et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 2010, 11:854-861.
37. Vieira P.L., et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol. 2004, 172:5986-5993.
38. Pot C., et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 2009, 183:797-801.
39. Gandhi R., et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3+ regulatory T cells. Nat. Immunol. 2010, 11:846-853.
40. Taga K., Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 1992, 148:1143-1148.
41. Taylor A., et al. IL-10 suppresses CD2-mediated T cell activation via SHP-1. Mol. Immunol. 2009, 46:622-629.
42. de Waal Malefyt R., et al. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J. Immunol. 1993, 150:4754-4765.
43. Kemper C., et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
44. Fiorentino D.F., et al. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 1991, 147:3815-3822.
45. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J. Exp. Med. 2007, 204:239-243.
46. Cardone J., et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 2010, 11:862-871.
47. Assenmacher M., et al. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur. J. Immunol. 1994, 24:1097-1101.
48. Del Prete G., et al. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 1993, 150:353-360.
49. Jankovic D., et al. Conventional T-bet+Foxp3- Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 2007, 204:273-283.
50. Cohen S.B., et al. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis Rheum. 1995, 38:946-952.
51. Morita Y., et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum. 1998, 41:1669-1676.
52. Yudoh K., et al. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis Rheum. 2000, 43:617-627.
53. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
54. Anderson C.F., et al. CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007, 204:285-297.
55. Jankovic D., et al. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 2010, 3:239-246.
56. Moore K.W., et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990, 248:1230-1234.
57. O'Garra A., Vieira P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 2004, 10:801-805.
58. Meiler F., et al. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J. Exp. Med. 2008, 205:2887-2898.
59. Gabrysova L., et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J. Exp. Med. 2009, 206:1755-1767.
60. Gabrysova L., Wraith D.C. Antigenic strength controls the generation of antigen-specific IL-10-secreting T regulatory cells. Eur. J. Immunol. 2010, 40:1386-1395.
61. McGeachy M.J., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
62. Safford M., et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 2005, 6:472-480.
63. Stumhofer J.S., et al. Negative regulation of Th17 responses. Semin. Immunol. 2007, 19:394-399.
64. Batten M., et al. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 2008, 180:2752-2756.
65. Spolski R., et al. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 2009, 182:2859-2867.
66. Meyaard L., et al. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J. Immunol. 1996, 156:2776-2782.
67. Le Friec G., Kemper C. Complement: coming full circle. Arch. Immunol. Ther. Exp. (Warsz) 2009, 57:393-407.
68. Astier A., et al. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 2000, 164:6091-6095.
69. Zaffran Y., et al. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 2001, 167:6780-6785.
70. Hawkins E.D., Oliaro J. CD46 signaling in T cells: Linking pathogens with polarity. FEBS Lett. 2010, 584:4838-4844.
71. Malek T.R., Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010, 33:153-165.
72. Saraiva M., et al. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009, 31:209-219.
73. Tsuji-Takayama K., et al. The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus. J. Immunol. 2008, 181:3897-3905.
74. Bodor J., et al. Regulatory T cell-mediated suppression: potential role of ICER. J. Leukoc. Biol. 2007, 81:161-167.
75. Szabo S.J., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
76. Inoue N., et al. Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol. Cell. Biol. 2003, 23:2614-2622.
77. Ricklin D., et al. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
78. Delpire E., Gagnon K.B. SPAK and OSR1: STE20 kinases involved in the regulation of ion homoeostasis and volume control in mammalian cells. Biochem. J. 2008, 409:321-331.
79. Astier A.L., et al. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 2006, 116:3252-3257.
80. Astier A.L., et al. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 2010, 184:685-693.
81. Shoemaker J., et al. GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells. J. Immunol. 2006, 176:3470-3479.
82. Stumhofer J.S., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
83. Amsen D., et al. The different faces of Notch in T-helper-cell differentiation. Nat. Rev. Immunol. 2009, 9:116-124.
84. Rutz S., et al. Notch regulates IL-10 production by T helper 1 cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3497-3502.
85. Le Friec G., et al. CD46: Just a Notch up your complement regulator. Mol. Immunol. 2010, 47:2229.
86. Chen J., Liu X.S. Development and function of IL-10 IFN-gamma-secreting CD4(+) T cells. J. Leukoc. Biol. 2009, 86:1305-1310.
87. Murphy K.M., Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11:674-680.
88. Strainic M.G., et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008, 28:425-435.